The story
1957
The Medical Development Corporation was founded in 1957 in Miami, Florida, by Dr. William P. Murphy Jr. and focused on interventional vascular medicine and neuroscience.
1959
The company's name was changed to Cordis.
1960s–1970s
Cordis expanded its portfolio of cardiovascular devices.
1996 - 1998
Johnson & Johnson acquired Cordis. and a year later, Cordis Corporation expanded into electrophysiology after Johnson & Johnson acquired Biosense Inc. and merged it with Cordis. In 1998, Biosense Inc. merged with Webster Laboratories to form Biosense Webster, Inc.
Read the full text
2015
Cardinal Health acquired the Cordis business from Johnson & Johnson for $1.944 billion. Cardinal Health acquired Cordis. Cardinal Health also owned Access Closure, Inc. (ACI), whose Mynx vascular closure portfolio became part of Cardinal Health's Medical segment alongside Cordis. On March 31, 2017, Cardinal Health announced two new strategic agreements that enabled Cordis, Cardinal Health's interventional vascular business, to expand its cardiology product offering in China.
2021
Cardinal Health divested Cordis and ACI in the same transaction to private equity firms Hellman & Friedman and KKR for $1 billion. The transaction was completed in August 2021.
2023
Cordis completes its acquisition of Swiss medical device company MedAlliance, adding the SELUTION SLR™ sirolimus drug-eluting balloon platform to its cardiovascular portfolio.
From Wikipedia’s article on Cordis (medical), shared under CC BY-SA 4.0.4